MDWD
MediWound Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$13.40
+0.37%Next report
Analyst consensus
- Next report date
- Nov 19, 2026
- EPS estimate
- -$0.71
- Revenue estimate
- $6.6M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.77
- EPS estimate
- -$0.76
- Revenue actual
- $3.1M
- Revenue estimate
- $2.7M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +36.9%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.76 | -$0.77 | Miss -1.09% | $3.1M |
| May 27, 2026 | -$0.65 | -$0.23 | Beat 64.62% | $1.5M |
| Mar 5, 2026 | -$0.65 | -$0.56 | Beat 13.85% | $1.9M |
| Nov 20, 2025 | -$0.81 | -$0.24 | Beat 70.37% | $5.4M |
| Aug 14, 2025 | -$0.55 | -$1.23 | Miss -123.64% | $5.7M |
| May 21, 2025 | -$0.65 | -$0.07 | Beat 89.23% | $4.0M |
| Mar 19, 2025 | -$0.59 | -$0.36 | Beat 38.98% | $5.8M |
| Nov 26, 2024 | -$0.44 | -$0.98 | Miss -122.73% | $4.4M |
| Aug 14, 2024 | -$0.42 | -$0.68 | Miss -61.90% | $5.1M |
| May 29, 2024 | -$0.40 | -$0.39 | Beat 2.50% | $5.0M |
| Mar 21, 2024 | -$0.23 | -$0.19 | Beat 17.39% | $5.3M |
| Nov 21, 2023 | -$0.45 | -$0.24 | Beat 46.67% | $4.8M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 19, 2026